Form 4 for CGON CG Oncology, Inc.
Accepted 2025-10-10 00:00:00 ET · period of report 2025-10-09 · accession 0001193125-25-237104 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-10-10 | 2025-10-09 | CGON | Mulay James | Dir | S - Sale+OE | $43.99 | -5,903 | 0 | -100% | -$259.7K |
| DT | 2025-10-10 | 2025-10-09 | CGON | Mulay James | Dir | M - OptEx | $3.72 | +5,903 | 5,903 | New | +$22.0K |
| DT | 2025-10-10 | 2025-10-09 | CGON | Mulay James | Dir | M - OptEx | $0.00 | -5,903 | 1,962 | -75% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-09 | S | D | 5,903 | $43.99 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2025-10-09 | M | A | 5,903 | $3.72 | 5,903 | D | — | — | |
| 3 | Derivative | Director Stock Option (right to buy) | 2025-10-09 | M | D | 5,903 | $0.00 | 1,962 | D | $3.72 · — to 2033-06-13 | 5,903 Common Stock | (F2) The stock option vests in 36 substantially equal monthly installments beginning on July 14, 2023. |